Navigation Links
Neil Bush Joins Board of Directors for Greffex, a Pioneering Vaccine Company

Greffex, a pioneering vaccine and gene therapy company based in Houston, Texas, welcomes Mr. Neil Bush to its Board of Directors.

“Neil understands the need for a global perspective to make an impact in a post pandemic world,” said Co-Chairman John Price, also President and CEO of Greffex. Mr. Bush will serve as an independent
director of the company.

“The Greffex board is excited to have Neil as a part of the team. He has vast international experience with a history of knowing, and advising, the most powerful companies and leaders in the world. Neil will be a huge asset to drive our future growth and enable Greffex’s mission to create innovative therapies that protect and heal mankind,” said Price.

Bush is an international businessman who operates through Neil Bush Global Advisers. He is Chairman of Singhaiyi, a Singapore publicly listed company; Co-Chairman of CIIC, a property development business in China; and, Chairman of A&A Consulting, a global platform that provides bridging services between the United States and Asia in health care, education, and technology in the USA.

“I can think of no better way to serve”, said Bush. “I am very excited to join the Greffex board to help advance the critically important work of implementing one of the world’s first universal vaccine platform to address the Covid-19 pandemic, and save lives, while enhancing the world’s capability to quickly respond to future pandemics. Based on testimonials of experts I am confident that Greffex will be successful — we must be successful!”

Mr. Bush also serves as Chairman of the Points of Light Board of Directors and Chairman of the Advisory Board of the Bush School of Government and Public Service. In these roles, Mr. Bush expands his father’s vision of inspiring, equipping and mobilizing volunteers to address serious social issues and training future generations of public and nonprofit leaders.

Mr. Bush will join a Board that includes:
John P Price, Greffex Co-Chairman, President and CEO
Uwe D. Staerz, M.D., Ph.D., Greffex Chief Scientist & Co-Chairman
Robert A. Eckels JD, Greffex Executive Vice President & General Counsel. Past Harris County Texas Judge
William S. Connolly, Greffex Executive Vice President
Sir Walter Bodmer, PhD, FRS, Head, Cancer & Immunogenetics Laboratory, University of Oxford
Chase Untermeyer, Former US Ambassador to Qatar
Jehan A. Al-Meer, MSC, PhD, MPA, MBA, Founder and CEO of Innovation Capital Qatar
R. Phil Zobrist, Real Estate Management and Development Entrepreneur
John D. White, JD., Chairman emeritus, Texas A&M University System Board of Regents

Greffex, a leading genetic engineering company, is a leader in developing a plug and play vaccine platform that delivers unprecedented time-to-market, cost efficiency, efficacy and safety through the use of proprietary clean viral vectors.

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology news :

1. Former FDA Branch Chief of Radiation Programs Joins NDA Partners as Expert Consultant
2. ExoRenal joins The LaunchPort™ Medical Device Accelerator
3. Jason Burke Joins CREO, Inc. as Partner to Head Analytics and Data Sciences Practice
4. Marque D. Todd, MS, DVM, DABT, Joins NDA Partners as Regulatory Toxicology Expert
5. Senior Regulatory Affairs and Program Management Executive, Robert Peterson, RAC, Joins NDA Partners
6. Former Vice President and Global Head of Quantitative Clinical Pharmacology at AstraZeneca Joins NDA Partners
7. Former OrthoLogic Quality Assurance Director, Donna Hartzfeld, PhD, Joins NDA Partners
8. Meredith James, HT, PMP, Joins Flagship Biosciences as Vice President of Operations
9. Former Vice President, Biometrics at GRAIL, Inc., Tara Maddala, PhD, Joins NDA Partners as Expert Consultant
10. Neal O’Farrell, Leading Cybersecurity Expert and Executive Director of the Identity Theft Council, Joins the Taliware™ Advisory Board
11. Jessica Wein Joins Lifecycle Biotechnologies As Marketing Strategist
Post Your Comments:
(Date:6/23/2020)... ... June 23, 2020 , ... ... services, today announced that the company has received ISO9001:2015 certification for the ... and research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s commitment ...
(Date:6/23/2020)... TORONTO (PRWEB) , ... June 22, 2020 , ... The ... time. Typically, ligand binding assays (LBA) have dominated this area. However, the use of ... several years. , This now necessitates the question “How do you choose which approach ...
(Date:6/23/2020)... ... ... In its June 22 online post, business and technology news platform Superb Crew ... and director of stem cell biotechnology company Asymmetrex . Superb Crew decided to ... 5 it would begin offering free tissue stem cell counting at its ...
Breaking Biology News(10 mins):
(Date:8/3/2020)... ... 03, 2020 , ... Introducing Ardent Animal Health – MediVet Biologics rebrands company ... Known as MediVet Biologics since its formation in 2016, the company is relaunching ... Health will build on its base of innovative therapies for osteoarthritis and cancer. ...
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... ... and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing ... announced that they have entered into a strategic partnership whereby Catalent will provide ...
(Date:7/18/2020)... ... July 16, 2020 , ... After research model surgery and catheter implantation, ... surgery is only the beginning of a successful study, while protecting and accessing the ... Gien, Global Head of Surgery from Envigo in a live webinar ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... that Massachusetts Institute of Technology (MIT) has expanded the company’s exclusive license ... to move into the point-of-care diagnostic market, focusing initially on the SARS-CoV-2 ...
Breaking Biology Technology: